NRX Pharmaceuticals, Inc. (NRXP)
3.04
0.00 (0.00%)
USD |
NASDAQ |
May 06, 16:00
3.04
0.00 (0.00%)
After-Hours: 20:00
NRX Pharmaceuticals Total Liabilities (Quarterly) : 28.89M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Synergy CHC Corp. | 33.29M |
| IGC Pharma, Inc. | 2.289M |
| Lantern Pharma, Inc. | 4.505M |
| Vivos Therapeutics, Inc. | 26.70M |
| Definium Therapeutics, Inc. | 107.77M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 12.96M |
| Shareholders Equity (Quarterly) | -15.94M |
| Debt to Equity Ratio | -0.0396 |
| Current Ratio | 0.3111 |
| Net Debt Paydown Yield | 1.40% |